Skip to main
IRTC
IRTC logo

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 44%
Buy 50%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Technologies reported a revenue of $164.3 million in the fourth quarter of 2024, marking a significant year-over-year increase of 24%. The company’s gross margin improved to 70.0%, surpassing consensus expectations, which reflects operational efficiency and cost management. Furthermore, strong domestic demand for its Zio XT and Zio AT products, coupled with international expansion plans, positions iRhythm for sustained double-digit revenue growth in the coming years.

Bears say

iRhythm Technologies, Inc. has projected a significant revenue decline for the first quarter of 2025, estimating it will only account for 22.5% of their full-year revenue guidance of $675-685 million, which raises concerns about the company’s ability to maintain its revenue growth trajectory. Additionally, the company faces potential margin pressure due to anticipated low-single digit pricing headwinds and a risk of flat to down gross margins, compounded by uncertainties surrounding reimbursement rates for extended ECG services that could further strain revenues. Furthermore, the bear case scenario incorporates assumptions of declining average selling prices for their Zio XT product line, which may be only partially mitigated by expected double-digit volume growth and international expansion, illustrating an overall negative financial outlook.

iRhythm Technologies (IRTC) has been analyzed by 16 analysts, with a consensus rating of Buy. 44% of analysts recommend a Strong Buy, 50% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 16 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $129.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $129.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.